Early research (Phase 1)Study completedNCT00450827
What this trial is testing
Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 25